Open the bottlenecks, centralise ATMP coordination, say Dutch researchers
The Dutch advanced therapy medicinal products (ATMPs) field is highly fragmented and needs central coordination to unblock bottlenecks. Dutch researchers made the recommendations in a recent report offering insight gaining an efficient overview of ATMP regulations.